Conclusion
SPRINT is a pilot rehabilitation program that provides inpatient intensive therapies for pediatric patients with hematologic and oncologic diagnoses with significant functional deficits while hospitalized for acute medical care. For patients who cannot safely transition to inpatient rehabilitation due to acute medical issues, participation in SPRINT can result in significant functional gains. Despite therapy participation barriers mostly related to patient complaints and symptoms, participation in SPRINT is generally safe with no adverse events associated with the program. No significant difference in the levels of patients’ tiredness, sadness, nervousness, or pain between the start and end of SPRINT was detected on parent and self report.
Future directions of this study include ongoing data collection of additional SPRINT participants and potential subgroup analyses to characterize factors associated with functional outcomes. Utilization of a validated measure of subjective symptoms of children and adolescents with oncologic and hematologic diagnoses will also be considered.